2014: China enters the global vaccine market
China is gearing up to supply the world with affordable vaccines that fulfil all efficacy, safety and quality requirements. Jane Parry reports.
Bulletin of the World Health Organization 2014;92:626-627. doi: http://dx.doi.org/10.2471/BLT.14.020914
The global vaccine industry has long been dominated by a few multinational companies. But now that companies in China, India and other emerging economies are becoming major vaccine manufacturers and have started selling these vaccines on the international market, competition is set to increase and prices to come down.
For Jiankang Zhang, representative for PATH’s China Programmes, the growth of China’s vaccine industry is “a very positive development for global health, as governments and international procurement agencies will be able to afford more life-saving vaccines and thus protect more lives”.
Since 1987, vaccine quality for international procurement has been assured through the prequalification system that is managed by the World Health Organization (WHO). The “prequalified” stamp of approval means that these vaccines are consistently safe, effective and of high quality, and thus recommended for bulk purchase by the United Nations Children’s Fund (UNICEF) in 152 low and middle-income countries, the GAVI Alliance – which funds vaccines in 73 of these countries – and other agencies.
When WHO pre-qualified a Chinese-made vaccine for the first time last October, the move showed what Chinese vaccine manufacturers could potentially achieve and – in a sense – paved the way for others to follow suit….
China vaccine scandal spreads as it recalls defective products which may have been sold overseas
Public anger soared last month after leaked documents revealed concerns about pharmaceutical safety
Investigators found Changchun Changsheng Life Sciences Ltd had blended expired fluids in its vaccines and falsified records from as early as April 2014, the National Health Commission said in a statement.
The names of the overseas countries were not given, but the recall indicated the scandal gripping China may have spread to foreign markets.
The commission did not immediately respond to a request for comment.
Regulators ordered a production halt last month, but public anger soared after documents leaked online showed regulators had found inconsistencies in 2017 but failed to take immediate action. …
Apparently US quality control isn’t much better, but the point is that the chinese govt seems to have some kind of secret arrangement with the rockefeller financial aristocracy. You know, the people who arranged for the gutting of US industries. See below.
Even without the rockefeller factor, it takes a lot of gullibility to allow yourself to be injected with unknown substances without good reason, but even more so when those substances are imported from an economic and military rival. I mean seriously!